COMPANY

Evoq Therapeutics, Inc.

HQ: Ann Arbor, MI source · evoqtherapeutics.com ↗ · Midwest

Keywords: immunology

Location: Ann Arbor, MI · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1M (SBIR Phase II 5R44AI192013-02, continuation, notice Aug 20, 2026). NIH RePORTER 5R44AI192013-02 (Aug 20, 2026)
Evidence (1 event)
- Aug 20, 2026 · NIH RePORTER 5R44AI192013-02
  Organization: EVOQ THERAPEUTICS, INC.; City/State: ANN ARBOR, MI; Project number: 5R44AI192013-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-20; FY total cost (award amount): 1000000; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: NanoDiscs for Immune Modulation in Celiac Disease; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Aug 20, 2026 Grant Government grant — SBIR: $1M (annual award, as published), announced Aug 20, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Sep 19, 2025 Grant Government grant — SBIR: $1.05M (annual award, as published), announced Sep 19, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 18, 2025 Grant Government grant — SBIR: $988,943 (annual award, as published), announced Jun 18, 2025. Agency: NIH/NCATS. Source: government award database. source ↗

Last 2 years.

Aug 20, 2026 Government grant — SBIR: $1M (annual award, as published), announced Aug 20, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Sep 19, 2025 Government grant — SBIR: $1.05M (annual award, as published), announced Sep 19, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 18, 2025 Government grant — SBIR: $988,943 (annual award, as published), announced Jun 18, 2025. Agency: NIH/NCATS. Source: government award database. source ↗

Annual award amounts. Total $2.8M.

Aug 21, 2024 NIH award 5R44DK135218-02 FY2024: $756,491 awarded for that fiscal year; activity R44 (SBIR); PI DANIEL, WESTON; recipient as written: EVOQ THERAPEUTICS, INC., ANN ARBOR, MI. New approach for immune modulation agains source ↗
Jul 11, 2024 NIH award 9R44TR005293-02 FY2024: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI DANIEL, WESTON; recipient as written: EVOQ THERAPEUTICS, INC., ANN ARBOR, MI. Novel immunotherapy against MOG antibod source ↗
Sep 19, 2023 NIH award 1R44DK135218-01A1 FY2023: $761,809 awarded for that fiscal year; activity R44 (SBIR); PI DANIEL, WESTON; recipient as written: EVOQ THERAPEUTICS, INC., ANN ARBOR, MI. New approach for immune modulation agai source ↗
Jul 15, 2022 NIH award 1R43AI172705-01 FY2022: $287,733 awarded for that fiscal year; activity R43 (SBIR); PI BARRETT, GREG; recipient as written: EVOQ THERAPEUTICS, INC., ANN ARBOR, MI. Novel immunotherapy against MOG antibody d source ↗